Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes

NCT00698789 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

48

Enrollment

INDUSTRY

Sponsor class

Stopped Study ended after diabetes development plan review. .

Conditions

Type 2 Diabetes

Interventions

DRUG: INCB019602
DRUG: INCB019602
DRUG: INCB019602
DRUG: INCB019602
DRUG: INCB019602
DRUG: Placebo
DRUG: Metformin

Sponsor

Incyte Corporation